Waldenström's macroglobulinemia laboratory findings

Waldenström's macroglobulinemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Waldenström's macroglobulinemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Bone Marrow Aspiration and Biopsy
Electrophoresis and Immunofixation
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Waldenström's macroglobulinemia laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Waldenström's macroglobulinemia laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Waldenström's macroglobulinemia laboratory findings
CDC on Waldenström's macroglobulinemia laboratory findings
Waldenström's macroglobulinemia laboratory findings in the news
Blogs on Waldenström's macroglobulinemia laboratory findings
Directions to Hospitals Treating Waldenström's macroglobulinemia
Risk calculators and risk factors for Waldenström's macroglobulinemia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]

Overview

Elevated beta-2-microglobulin and abnormal coagulation studies are characteristic of waldenström's macroglobulinemia.

Laboratory Findings

Complete blood count

• Normocytic normochromic anemia: presents in 80% of patients
• Leukopenia
• Thrombocytopenia: presents in 50% of patients with bleeding diathesis

Peripheral smear

• Plasmacytoid lymphocytes
• Normocytic normochromic red blood cells
• Rouleaux formation

Chemistry lab tests

• Elevated beta-2-microglobulin in proportion to tumor mass
• Elevated lactate dehydrogenase
• Elevated creatinine
• Electrolyte abnormalities:

• Hypercalcemia(4%)

• Elevated erythrocyte sedimentation rate and uric acid
• Total protein levels
• Albumin-to-globulin ratio
• Rheumatoid factor, cryoglobulins, direct anti-globulin test, and cold agglutinin titre results can be positive.
• Coagulation studies can be abnormal with elevated prothrombin time, activated partial thromboplastin time, and thrombin time.

Plasma viscosity

• Plasma viscosity should be measured in patients presenting with hyperviscosity syndrome whenever the monoclonal IgM protein spike is >4 g/dL.
• The normal plasma viscosity is 1.8 centipoise.
• Patients start presenting with hyperviscosity symptoms when viscosity >4 centipoise.